This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Jimro Co., Ltd.. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Kenta Kaneda: Innovator in Anti-Drug Antibody Measurement
Introduction
Kenta Kaneda is a notable inventor based in Takasaki, Japan. He has made significant contributions to the field of molecular-targeted therapy through his innovative methods. His work focuses on improving the accuracy and simplicity of measuring anti-drug antibodies in patients.
Latest Patents
Kenta Kaneda holds a patent for a method that measures anti-drug antibodies (ADAs) in patients receiving molecular-targeted therapy. This method provides a simpler and more accurate approach to monitoring these antibodies, which is crucial for effective treatment.
Career Highlights
Kaneda is associated with Jimro Co., Ltd., where he applies his expertise in developing advanced medical technologies. His work has been instrumental in enhancing patient care through innovative solutions.
Collaborations
Kenta Kaneda has collaborated with notable colleagues, including Nobuhito Kashiwagi and Fumio Saitoh. These partnerships have contributed to the advancement of research and development in their field.
Conclusion
Kenta Kaneda's contributions to the measurement of anti-drug antibodies represent a significant advancement in medical technology. His innovative methods are paving the way for improved patient outcomes in molecular-targeted therapy.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile